MicroRNA-218 inhibits the migration, epithelial-mesenchymal transition and cancer stem cell properties of prostate cancer cells

Oncology Letters
Bing GuanYuefeng Du

Abstract

MicroRNA (miRNA) is a class of non-coding single-stranded RNA, able to regulate tumor-associated genes via binding the 3'-UTR of the target gene mRNA. Previous publications have demonstrated that miRNA-218 (miR-218) acts as a tumor-suppressive miRNA in various types of human cancer, including prostate cancer (PCa). However, the role of miR-218 in regulating PCa cell stemness and epithelial-mesenchymal transition remains unknown and requires further research. In the present study, it is demonstrated that miR-218 was downregulated in 2 PCa cell lines and could suppress cell migration, EMT and the exhibition of cancer stem cell-like properties. The expression of GLI family zinc finger 1 (Gli1) was inhibited by miR-218 overexpression, suggesting miR-218-suppression of Gli1 as a potential mechanism for the tumor-suppressive effect of miR-218. Overall, the results indicate that miR-218 served a critical role in the inhibition of PCa development. This may provide new insight for elucidating the mechanisms of PCa oncogenesis and suggests that miR-218 may be a novel therapeutic target for PCa.

References

Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Aug 16, 2005·Current Opinion in Genetics & Development·Eric A Miska
Aug 17, 2005·Cancer Research·Marilena V IorioCarlo M Croce
Sep 9, 2005·Nature Reviews. Cancer·Thomas BrabletzThomas Kirchner
Jan 2, 2007·Current Biology : CB·Virginie ClementAriel Ruiz i Altaba
Nov 4, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Marilena V Iorio, Carlo M Croce
Dec 1, 2009·Cell·Jean Paul ThieryM Angela Nieto
Sep 15, 2010·PloS One·Morgan R DavidsonKwun M Fong
Oct 5, 2010·Nature Reviews. Drug Discovery·Ramiro GarzonCarlo M Croce
Dec 15, 2010·Nature Reviews. Clinical Oncology·Naoko TakebeS Percy Ivy
Feb 8, 2011·CA: a Cancer Journal for Clinicians·Ahmedin JemalDavid Forman
Jan 24, 2012·Breast Cancer Research : BCR·Bhuvanesh DaveJenny C Chang
Jul 5, 2012·Cancer Research·Shingo InagumaHiroshi Ikeda
May 31, 2013·The Journal of Clinical Endocrinology and Metabolism·Hongyu GuanYanbing Li
Sep 17, 2013·Journal of Cellular Physiology·Alia AhmedFazlul H Sarkar
Oct 22, 2013·Cancer Treatment Reviews·Alison EganOliver Sartor
Aug 28, 2014·The FEBS Journal·Selcuk Colak, Jan P Medema
Dec 7, 2014·Asian Pacific Journal of Tropical Medicine·Hong-Tai WangKun Chen
Dec 17, 2014·Biochemical and Biophysical Research Communications·Guangye HanXinjun Zhang
Dec 23, 2014·Oncology Reports·Zhonghui ZhengJunjie Wang
May 15, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Yidong ChengQiang Lu
Nov 9, 2016·Molecular Cancer·Abhijeet DeshmukhArun Dharmarajan

❮ Previous
Next ❯

Citations

Mar 17, 2021·Biochemical Genetics·Diba Borzabadi FarahaniMohammad Reza Fattahi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.